Al-Ruzzeh Sharif, Nakamura Koki, Athanasiou Thanos, Modine Thomas, George Shane, Yacoub Magdi, Ilsley Charles, Amrani Mohamed
The National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, Harefield Hospital, Harefield, Middlesex UB9 6JH, UK.
Eur J Cardiothorac Surg. 2003 Jan;23(1):50-5. doi: 10.1016/s1010-7940(02)00654-1.
Although there has been some evidence supporting the theoretical and practical advantages of off-pump coronary artery bypass (OPCAB) over the conventional coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB), it has not yet been determined which group of patients would benefit most from it. It has been advocated recently that high-risk patients could benefit most from avoidance of CPB. The aim of this retrospective study is to assess the efficacy of the OPCAB technique in multi-vessel myocardial revascularization in a large series of high-risk patients.
The records of 1398 consecutive high-risk patients who underwent primary isolated CABG at Harefield Hospital between August 1996 and December 2001 were reviewed retrospectively. Patients were considered as high-risk and included in the study if they had a preoperative EuroSCORE of > or =5. Two hundred and eighty-six patients were operated on using the OPCAB technique while 1112 patients were operated on using the conventional CABG technique with CPB. The OPCAB patients were significantly older than the CPB patients (68.1+/-8.3 vs. 63.7+/-9.9 years, respectively, P<0.001). The OPCAB group included significantly more patients with poor left ventricular (LV) function (ejection fraction (EF) < or =30%) (P<0.001) and more patients with renal problems (P<0.001).
There was no significant difference in the number of grafts between the groups. The CPB patients received 2.8+/-1.2 grafts per patient while OPCAB patients received 2.8+/-0.5 grafts per patient (P=1). Twenty-one (7.3%) OPCAB patients had one or more major complications, while 158 (14.2%) CPB patients (P=0.008) developed major complications. Thirty-eight (3.4%) CPB patients developed peri-operative myocardial infarction (MI) while only two (0.7%) OPCAB patients developed peri-operative MI (P=0.024). The intensive therapy unit (ITU) stay for OPCAB patients was 29.3+/-15.4 h while for CPB patients it was 63.6+/-167.1 h (P<0.001). There were ten (3.5%) deaths in the OPCAB patients compared to 78 (7%) deaths in the CPB patients (P=0.041) within 30 days postoperatively.
This retrospective study shows that using the OPCAB technique for multi-vessel myocardial revascularization in high-risk patients significantly reduces the incidence of peri-operative MI and other major complications, ITU stay and mortality. Even though the OPCAB group included a significantly higher proportion of older patients with poor LV function (EF < or =30%) and renal problems, the beneficial effect of OPCAB was evident.
尽管已有一些证据支持非体外循环冠状动脉搭桥术(OPCAB)相较于传统体外循环冠状动脉搭桥术(CABG)在理论和实践上的优势,但尚未确定哪类患者能从中获益最多。最近有人主张高危患者可从避免体外循环中获益最多。本回顾性研究的目的是评估OPCAB技术在一系列高危患者多支血管心肌血运重建中的疗效。
回顾性分析1996年8月至2001年12月在哈雷菲尔德医院接受初次单纯CABG的1398例连续高危患者的记录。术前欧洲心脏手术风险评估系统(EuroSCORE)评分≥5分的患者被视为高危患者并纳入研究。286例患者采用OPCAB技术进行手术,而1112例患者采用传统CABG技术并使用体外循环。OPCAB组患者的年龄显著大于体外循环组(分别为68.1±8.3岁和63.7±9.9岁,P<0.001)。OPCAB组中左心室(LV)功能差(射血分数(EF)≤30%)的患者明显更多(P<0.001),有肾脏问题的患者也更多(P<0.001)。
两组间移植血管数量无显著差异。体外循环组患者人均移植2.8±1.2支血管,而OPCAB组患者人均移植2.8±0.5支血管(P = 1)。21例(7.3%)OPCAB患者发生了一种或多种主要并发症,而158例(14.2%)体外循环组患者(P = 0.008)发生了主要并发症。38例(3.4%)体外循环组患者发生围手术期心肌梗死(MI),而只有2例(0.7%)OPCAB组患者发生围手术期MI(P = 0.024)。OPCAB组患者在重症监护病房(ITU)的停留时间为29.3±15.4小时,而体外循环组患者为63.6±167.1小时(P<0.001)。术后30天内,OPCAB组有10例(3.5%)死亡,而体外循环组有78例(7%)死亡(P = 0.041)。
这项回顾性研究表明,在高危患者中使用OPCAB技术进行多支血管心肌血运重建可显著降低围手术期MI及其他主要并发症的发生率、在ITU的停留时间和死亡率。尽管OPCAB组中年龄较大、LV功能差(EF≤30%)且有肾脏问题的患者比例明显更高,但OPCAB的有益效果仍很明显。